ArticleCanadian journal of kidney health and disease2014

A budget impact analysis of the introduction of erythropoiesis stimulating agent subsequent entry biologics for the treatment of anemia of chronic kidney disease in Canada.

Nicole W Tsao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.